Breaking News

NEW YORK, Aug. 23 – Rosetta Inpharmatics has licensed its Resolver gene expression data analyzer to functional genomics company Europroteome, Rosetta said on Thursday.

NEW YORK, Aug. 23 – Eli Lilly and Co.

NEW YORK, Aug. 15 – Merck has acquired a non-exclusive license to Lexicon Genetics' gene-targeting technologies, bringing to 16 the total number of licensees for the technologies, Lexicon said on Wednesday.

NEW YORK, Aug. 22 – Researchers at the University of Washington School of Medicine earlier this week announced that they have finished sequencing and annotating  Agrobacterium tumefaciens , a bacterium with a unique ability to insert genetic material into other organisms.

NEW YORK, Aug. 22 – Genomics Collaborative said on Wednesday that it has signed up its first five biopharmaceutical companies to access its newly launched database of DNA, sera, and tissue samples.

NEW YORK, Aug 22 – Galapagos Genomics is collaborating with Vertex Pharmaceuticals to identify the function of various proteins, the company announced Wednesday.

NEW YORK, Aug. 22 – Galapagos Genomics is collaborating with Vertex Pharmaceuticals to identify the function of various proteins, the company announced on Wednesday.

NEW YORK, Aug. 22 – Gilead Sciences is selling its 49 percent interest in oligonucleotides manufacturer Proligo to Degussa Corporation, which currently holds the remaining Proligo shares, the company announced on Wednesday. The deal, expected to close on Aug.

NEW YORK, Aug. 21 – Third Wave Technologies and researchers from two academic centers in the US have applied the company’s Invader SNP-detection technology to a microarray platform, Third Wave said on Tuesday.

NEW YORK, Aug. 21 – Thermo Finnigan and Proteome Systems have entered into an agreement to integrate and distribute selected items of each other’s products, the companies announced Tuesday.

NEW YORK, Aug. 20 – Plagued by deteriorating customer demand and excess capacity, Agilent Technologies on Monday said it would cut 4,000 jobs, or 9 percent of its work force, and posted a third-quarter operating loss.

NEW YORK, Aug. 20 – Paradigm Genetics has developed a microarray for the rice pathogen Magnaporthe grisea, the company said on Monday.

NEW YORK, Aug.

NEW YORK, August 17 – GeneProt has appointed Bertrand Damour chief financial officer, Stephen Macevicz, vice president of intellectual property, and Diana Wetmore chief technical officer for the Geneva branch, the company announced on Friday.

We all have expectations: warm, sunny weather in the summer, snow in the winter. But as we all know, sometimes what we expect is not what we get, and we are forced to deal with scorching heat in July and blizzards in January.

Pages

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.